Faculty of Medical Science, Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil.
Unit of Liver Transplantation, Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil.
Braz J Infect Dis. 2014 Mar-Apr;18(2):220-4. doi: 10.1016/j.bjid.2013.07.007. Epub 2013 Nov 22.
Herpesvirus reactivation is common after liver transplantation.
Analyze the presence of cytomegalovirus (HCMV) and human herpesvirus-6 (HHV-6) DNA in liver donor biopsies, seeking to better understand issues involving human donor leukocyte antigens (HLA)-A, B and DR, as well as correlations with acute cellular rejection.
Fifty-nine liver transplantation patients were investigated for the presence of HCMV and HHV-6 DNA in liver donor biopsies, using the Nested-PCR technique. The clinical donor information and HLA matches were obtained from the São Paulo State Transplant System. The recipients' records regarding acute cellular rejection were studied.
Seven (11.8%) biopsies were positive for HCMV DNA and 29 (49%) were positive for HHV-6 DNA. In 14 donors with HLA-DR 15 nine had HHV-6 DNA positive liver biopsy with a tendency for significant association (p=0.09), 22 recipients developed acute cellular rejection and 9/22 were positive for HLA-DR 15 (p=0.03; χ(2)=4.51), which was statistically significant in univariate analysis and showed a tendency after multivariate analysis (p=0.08).
HHV-6 DNA was prevalent in liver donors studied as well as HLA-DR 15. These findings suggest that patients with HLA-DR 15 in liver donor biopsies develop more rejection after liver transplantation.
肝移植后疱疹病毒再激活很常见。
分析肝供体活检中巨细胞病毒(CMV)和人类疱疹病毒-6(HHV-6)DNA 的存在情况,以期更好地了解与人类供体白细胞抗原(HLA)-A、B 和 DR 相关的问题,以及与急性细胞排斥的相关性。
使用巢式 PCR 技术,对 59 例肝移植患者肝供体活检中 CMV 和 HHV-6 DNA 的存在情况进行了调查。临床供体信息和 HLA 匹配情况从圣保罗州移植系统获得。研究了受者关于急性细胞排斥的记录。
7 例(11.8%)活检标本 CMV DNA 阳性,29 例(49%)HHV-6 DNA 阳性。在 14 例 HLA-DR 15 阳性的供体中,有 9 例肝活检 HHV-6 DNA 阳性,存在显著相关性的趋势(p=0.09),22 例受者发生急性细胞排斥,9/22 例 HLA-DR 15 阳性(p=0.03;χ²=4.51),单因素分析有统计学意义,多因素分析后呈趋势(p=0.08)。
在所研究的肝供体中,HHV-6 DNA 与 HLA-DR 15 均较常见。这些发现表明,肝供体活检中 HLA-DR 15 的患者在肝移植后发生排斥反应的可能性更大。